Metastatic Cancer Global Clinical Trials Review, H1, 2012
Summary
GlobalData's clinical trial report, “Metastatic Cancer Global Clinical Trials Review, H1, 2012' provides data on the Metastatic Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Reasons to buy
Keywords
Metastatic Cancer Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Metastatic Cancer , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Summary
GlobalData's clinical trial report, “Metastatic Cancer Global Clinical Trials Review, H1, 2012' provides data on the Metastatic Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Metastatic Cancer Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Metastatic Cancer , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Introduction
Metastatic Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Metastatic Cancer
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Metastatic Cancer Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Genentech, Inc.
Clinical Trial Overview of Genentech, Inc.
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Hoffmann-La Roche Inc.
Clinical Trial Overview of Hoffmann-La Roche Inc.
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Novartis AG
Clinical Trial Overview of Novartis AG
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Taiho Pharmaceutical Co., Ltd.
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd.
Sanofi
Clinical Trial Overview of Sanofi
Bayer AG
Clinical Trial Overview of Bayer AG
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Eisai Inc.
Clinical Trial Overview of Eisai Inc.
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
ImClone LLC
Clinical Trial Overview of ImClone LLC
Chugai Pharmaceutical Co., Ltd.
Clinical Trial Overview of Chugai Pharmaceutical Co., Ltd.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Sarah Cannon Research Institute
Clinical Trial Overview of Sarah Cannon Research Institute
University Health Network
Clinical Trial Overview of University Health Network
University of Medicine and Dentistry New Jersey
Clinical Trial Overview of University of Medicine and Dentistry New Jersey
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
FUDAN University
Clinical Trial Overview of FUDAN University
Vanderbilt-Ingram Cancer Center
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center
H. Lee Moffitt Cancer Center & Research Institute
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
Fox Chase Cancer Center
Clinical Trial Overview of Fox Chase Cancer Center
The University of Chicago
Clinical Trial Overview of The University of Chicago
Southeastern Medical Oncology Center
Clinical Trial Overview of Southeastern Medical Oncology Center
Duke University
Clinical Trial Overview of Duke University
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
University of Michigan Comprehensive Cancer Center
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center
Northwestern University
Clinical Trial Overview of Northwestern University
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, BRIC Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, G7 Countries, 2012*
Metastatic Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Cancer Therapeutics Clinical Trials, E7 Countries, 2012*
Metastatic Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Metastatic Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012*
Metastatic Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Metastatic Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Metastatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoffmann-La Roche Inc., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ImClone LLC, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Chugai Pharmaceutical Co., Ltd., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeastern Medical Oncology Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012*
LIST OF FIGURES
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Metastatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Metastatic Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Metastatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
Metastatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012*
Metastatic Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Metastatic Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012*
Metastatic Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012*
Metastatic Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Metastatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology
Metastatic Cancer
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Metastatic Cancer
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Metastatic Cancer Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Genentech, Inc.
Clinical Trial Overview of Genentech, Inc.
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Hoffmann-La Roche Inc.
Clinical Trial Overview of Hoffmann-La Roche Inc.
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Novartis AG
Clinical Trial Overview of Novartis AG
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
Taiho Pharmaceutical Co., Ltd.
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd.
Sanofi
Clinical Trial Overview of Sanofi
Bayer AG
Clinical Trial Overview of Bayer AG
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Eisai Inc.
Clinical Trial Overview of Eisai Inc.
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
ImClone LLC
Clinical Trial Overview of ImClone LLC
Chugai Pharmaceutical Co., Ltd.
Clinical Trial Overview of Chugai Pharmaceutical Co., Ltd.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Sarah Cannon Research Institute
Clinical Trial Overview of Sarah Cannon Research Institute
University Health Network
Clinical Trial Overview of University Health Network
University of Medicine and Dentistry New Jersey
Clinical Trial Overview of University of Medicine and Dentistry New Jersey
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
FUDAN University
Clinical Trial Overview of FUDAN University
Vanderbilt-Ingram Cancer Center
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center
H. Lee Moffitt Cancer Center & Research Institute
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
Fox Chase Cancer Center
Clinical Trial Overview of Fox Chase Cancer Center
The University of Chicago
Clinical Trial Overview of The University of Chicago
Southeastern Medical Oncology Center
Clinical Trial Overview of Southeastern Medical Oncology Center
Duke University
Clinical Trial Overview of Duke University
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
University of Michigan Comprehensive Cancer Center
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center
Northwestern University
Clinical Trial Overview of Northwestern University
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source
LIST OF TABLES
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, BRIC Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, G7 Countries, 2012*
Metastatic Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Cancer Therapeutics Clinical Trials, E7 Countries, 2012*
Metastatic Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Metastatic Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012*
Metastatic Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Metastatic Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Metastatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hoffmann-La Roche Inc., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ImClone LLC, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Chugai Pharmaceutical Co., Ltd., 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeastern Medical Oncology Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012*
Metastatic Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012*
LIST OF FIGURES
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Metastatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Metastatic Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Metastatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
Metastatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012*
Metastatic Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Metastatic Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012*
Metastatic Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012*
Metastatic Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Metastatic Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Metastatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Metastatic Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology